Institutional Ownership Acadia Pharmaceuticals Inc (ACAD)
This table provides information about the institutional ownership of Acadia Pharmaceuticals Inc (ACAD). We have compiled data on the 358 institutions that hold shares in the stock, with a total of 163 Million shares, which have been reported (via 13F filing form) to have a value of $3.64 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Rockefeller Capital Management L.P.
New York, NY |
May 14, 2025 Q1 2025 |
1,138,094
shares
|
$25.7 Million
0.05% of portfolio
|
Q1 2025
Reduced 2.18%
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
1,056,850
shares
|
$23.9 Million
0.0% of portfolio
|
Q1 2025
Reduced 14.86%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
967,500
shares
|
$21.8 Million
0.04% of portfolio
|
Q1 2025
Reduced 23.41%
|
|
Eventide Asset Management, LLC
Boston, MA |
May 15, 2025 Q1 2025 |
852,845
shares
|
$19.2 Million
0.3% of portfolio
|
Q4 2024
Added 47.68%
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
816,656
shares
|
$18.4 Million
0.03% of portfolio
|
Q1 2025
Reduced 34.32%
|
|
Emerald Advisers, LLC
|
May 01, 2025 Q1 2025 |
815,905
shares
|
$18.4 Million
0.67% of portfolio
|
Q1 2025
Reduced 1.11%
|
|
Bank Of New York Mellon Corp
New York, NY |
Apr 29, 2025 Q1 2025 |
804,390
shares
|
$18.2 Million
0.0% of portfolio
|
Q1 2025
Added 96.31%
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
May 15, 2025 Q1 2025 |
804,119
shares
|
$18.1 Million
0.01% of portfolio
|
Q1 2025
Added 28.04%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
760,594
shares
|
$17.2 Million
0.01% of portfolio
|
Q4 2024
Added 37.06%
|
|
Principal Financial Group Inc
Des Moines, IA |
Apr 28, 2025 Q1 2025 |
754,748
shares
|
$17 Million
0.01% of portfolio
|
Q1 2025
Added 425.25%
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
731,576
shares
|
$16.5 Million
0.0% of portfolio
|
Q1 2025
Added 42.8%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
720,237
shares
|
$16.3 Million
0.0% of portfolio
|
Q1 2025
Added 5.78%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
May 14, 2025 Q1 2025 |
696,825
shares
|
$15.7 Million
0.0% of portfolio
|
Q1 2025
Reduced 21.25%
|
|
Rice Hall James & Associates, LLC
|
May 01, 2025 Q1 2025 |
672,223
shares
|
$15.2 Million
0.73% of portfolio
|
Q1 2025
Reduced 1.37%
|
|
Panagora Asset Management Inc
Boston, MA |
May 15, 2025 Q1 2025 |
653,759
shares
|
$14.8 Million
0.06% of portfolio
|
Q1 2025
Reduced 0.21%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
649,379
shares
|
$14.7 Million
0.0% of portfolio
|
Q1 2025
Added 4.57%
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
649,210
shares
|
$14.7 Million
0.01% of portfolio
|
Q1 2025
Added 2.82%
|
|
Great Lakes Advisors, LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
612,680
shares
|
$13.8 Million
0.1% of portfolio
|
Q1 2025
Added 13.46%
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
May 12, 2025 Q1 2025 |
572,261
shares
|
$12.9 Million
0.05% of portfolio
|
Q1 2025
Reduced 16.55%
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
May 15, 2025 Q1 2025 |
523,029
shares
|
$11.8 Million
0.06% of portfolio
|
Q1 2025
Reduced 17.57%
|
|
Emerald Mutual Fund Advisers Trust
|
May 01, 2025 Q1 2025 |
495,084
shares
|
$11.2 Million
0.67% of portfolio
|
Q1 2025
Reduced 1.06%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
470,338
shares
|
$10.6 Million
0.49% of portfolio
|
Q1 2024
Reduced 35.65%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 05, 2025 Q1 2025 |
434,956
shares
|
$9.82 Million
0.01% of portfolio
|
Q1 2025
Reduced 6.95%
|
|
Janus Henderson Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
425,903
shares
|
$9.61 Million
0.0% of portfolio
|
Q1 2025
Added 706.27%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
425,470
shares
|
$9.6 Million
0.0% of portfolio
|
Q1 2025
Reduced 53.93%
|